Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Francesco Panza, Vincenzo Solfrizzi, Bruno P Imbimbo, Rosanna Tortelli, Andrea Santamato & Giancarlo Logroscino. (2014) Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward. Expert Review of Clinical Immunology 10:3, pages 405-419.
Read now
Read now
Articles from other publishers (44)
Sorachat Tharamak, Tipanan Wisarutwanit, Weerasak Songoen, Patchreenart Saparpakorn & Wanchai Pluempanupat. (2023) Synthesis and Acetylcholinesterase Inhibitory Evaluation of Coumarin‐Linked Carbazole Derivatives. ChemistrySelect 8:46.
Crossref
Crossref
Samet Evyapan, Emine Elçin Oruç‐Emre, Yusuf Sıcak, Ayşegül Karaküçük‐İyidoğan, Gizem Tatar Yılmaz & Mehmet Öztürk. (2023)
Design,
in Silico
Studies and Biological Evaluation of New Chiral Thiourea and 1,3‐Thiazolidine‐4,5‐dione Derivatives
. Chemistry & Biodiversity.
Crossref
Crossref
Rashu Raju, Anjali Nayak, Paramita Das, Anmol Gajmer, Ramya A & Tejaswini R. (2023) Advanced prodrug approaches for neurodegenerative diseases. Brazilian Journal of Science 2:10, pages 1-12.
Crossref
Crossref
Jinjing Yao & S. R. Wayne Chen. (2022) R-carvedilol, a potential new therapy for Alzheimer’s disease. Frontiers in Pharmacology 13.
Crossref
Crossref
Yajing Liu, Jinjing Yao, Zhenpeng Song, Wenting Guo, Bo Sun, Jinhong Wei, John Paul Estillore, Thomas G. Back & S. R. Wayne Chen. (2021) Limiting RyR2 open time prevents Alzheimer's disease‐related deficits in the 3xTG‐AD mouse model. Journal of Neuroscience Research 99:11, pages 2906-2921.
Crossref
Crossref
Armita Mahdavi Gorabi, Saeed Aslani, George E. Barreto, Eliana Báez-Jurado, Nasim Kiaie, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2021) The potential of mitochondrial modulation by neuroglobin in treatment of neurological disorders. Free Radical Biology and Medicine 162, pages 471-477.
Crossref
Crossref
Yihan Zhao, Kai Zheng, Baoyi Guan, Mengmeng Guo, Lei Song, Jie Gao, Hua Qu, Yuhui Wang, Dazhuo Shi & Ying Zhang. (2020) DLDTI: a learning-based framework for drug-target interaction identification using neural networks and network representation. Journal of Translational Medicine 18:1.
Crossref
Crossref
D. Sivaraman, P.S. Pradeep, S. Sundar Manoharan, C. Ramachandra Bhat, K.V. Leela & V. Venugopal. (2020) Revealing Potential Binding Affinity of FDA Approved Therapeutics Targeting Main Protease (3CLpro) in Impairing Novel Coronavirus (SARSCoV- 2) Replication that Causes COVID-19. Coronaviruses 1:1, pages 98-107.
Crossref
Crossref
A.A.D.T. Abeysinghe, R.D.U.S. Deshapriya & C. Udawatte. (2020) Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions. Life Sciences 256, pages 117996.
Crossref
Crossref
Shen Luo, Chi Ma, Ming-Qin Zhu, Wei-Na Ju, Yu Yang & Xu Wang. (2020) Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease. Frontiers in Cellular Neuroscience 14.
Crossref
Crossref
Gregory Klein, Paul Delmar, Nicola Voyle, Sunita Rehal, Carsten Hofmann, Danielle Abi-Saab, Mirjana Andjelkovic, Smiljana Ristic, Guoqiao Wang, Randall Bateman, Geoffrey A. Kerchner, Monika Baudler, Paulo Fontoura & Rachelle Doody. (2019) Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis. Alzheimer's Research & Therapy 11:1.
Crossref
Crossref
Danfang Yu, Huanhuan Yan, Jun Zhou, Xiaodan Yang, Youming Lu & Yunyun Han. (2019) A circuit view of deep brain stimulation in Alzheimer’s disease and the possible mechanisms. Molecular Neurodegeneration 14:1.
Crossref
Crossref
Patrycja Nowak-Sliwinska, Leonardo Scapozza & Ariel Ruiz i Altaba. (2019) Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1871:2, pages 434-454.
Crossref
Crossref
Rui-Rui Ding, Wang Chen, Cong-Ying Guo, Wei-Tao Liao, Xia Yang, Feng-Er Liao, Jing-Ming Lin, Han-Fang Mei & Yu Zeng. (2018) Dangguishaoyao-San attenuates LPS-induced neuroinflammation via the TLRs/NF-κB signaling pathway. Biomedicine & Pharmacotherapy 105, pages 187-194.
Crossref
Crossref
Jianping Guo, Ji Cheng, Brian J. North & Wenyi Wei. (2017) Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:2, pages 341-358.
Crossref
Crossref
Ilkay Erdogan Orhan, Fatma Sezer Senol, Suhaib Shekfeh, Krystyna Skalicka-Wozniak & Erden Banoglu. (2017) Pteryxin - A promising butyrylcholinesterase-inhibiting coumarin derivative from Mutellina purpurea. Food and Chemical Toxicology 109, pages 970-974.
Crossref
Crossref
Amelie T. van der Ven, Julius C. Pape, Dirk Hermann, Robert Schloesser, Just Genius, Nadine Fischer, Rainald Mößner, Norbert Scherbaum, Jens Wiltfang, Dan Rujescu & Jens Benninghoff. (2017) Methylene Blue (Tetramethylthionine Chloride) Influences the Mobility of Adult Neural Stem Cells: A Potentially Novel Therapeutic Mechanism of a Therapeutic Approach in the Treatment of Alzheimer’s Disease. Journal of Alzheimer's Disease 57:2, pages 531-540.
Crossref
Crossref
Babak Tousi, Cheryl Kanetsky & Nancy Udelson. (2016) ALZ i-Connect. American Journal of Alzheimer's Disease & Other Dementiasr 32:1, pages 63-66.
Crossref
Crossref
Teresa S. Wiley & Jason T. Haraldsen. (2017) Cyclic E2 and P4 on Alzheimer’s Disease Pathways. Advances in Alzheimer's Disease 06:01, pages 32-44.
Crossref
Crossref
Shaffali Singla & Poonam Piplani. (2016) Coumarin derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies. Bioorganic & Medicinal Chemistry 24:19, pages 4587-4599.
Crossref
Crossref
Po-Heng Tsai & Jeffrey L. Cummings. 2016. The Behavioral Neurology of Dementia. The Behavioral Neurology of Dementia
415
424
.
Tomohiro Miyasaka, Ce Xie, Satomi Yoshimura, Yuki Shinzaki, Sawako Yoshina, Eriko Kage-Nakadai, Shohei Mitani & Yasuo Ihara. (2016) Curcumin improves tau-induced neuronal dysfunction of nematodes. Neurobiology of Aging 39, pages 69-81.
Crossref
Crossref
Hyeong-Min Lee & Yuna Kim. (2016) Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders. Schizophrenia Research and Treatment 2016, pages 1-12.
Crossref
Crossref
Christian Behl & Christine ZieglerChristian Behl & Christine Ziegler. 2016. Molekulare Mechanismen der Zellalterung und ihre Bedeutung für Alterserkrankungen des Menschen. Molekulare Mechanismen der Zellalterung und ihre Bedeutung für Alterserkrankungen des Menschen
109
121
.
Mohammad Abbasinazari, Ladan Adib-Eshgh, Azin Rostami, Narges Beyraghi, Shideh Dabir & Reyhaneh Jafari. (2015) Memantine in the prevention or alleviation of electroconvulsive therapy induces cognitive disorders: A placebo controlled trial. Asian Journal of Psychiatry 15, pages 5-9.
Crossref
Crossref
Colin Johnson & Daniel Bressington. (2015) Increasing diagnosis rates of dementias: Holy grail or poisoned chalice?. British Journal of Mental Health Nursing 4:3, pages 111-115.
Crossref
Crossref
Nicholas J. Ashton, Steven J. Kiddle, John Graf, Malcolm Ward, Alison L. Baird, Abdul Hye, Sarah Westwood, Karyuan Vivian Wong, Richard J. Dobson, Gil D. Rabinovici, Bruce L. Miller, Howard J. Rosen, Andrew Torres, Zhanpan Zhang, Lennart Thurfjell, Antonia Covin, Cristina Tan Hehir, David Baker, Chantal Bazenet & Simon Lovestone. (2015) Blood protein predictors of brain amyloid for enrichment in clinical trials?. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 1:1, pages 48-60.
Crossref
Crossref
Young Hun Lee, Min Cheol Shin, Yong Don Yun, Seo Young Shin, Jong Min Kim, Jeong Moo Seo, Nam-Jung Kim, Jong Hoon Ryu & Yong Sup Lee. (2015) Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors. Bioorganic & Medicinal Chemistry 23:1, pages 231-240.
Crossref
Crossref
Hongjie Wang, Adel Nefzi, Gregg B. Fields, Madepalli K. Lakshmana & Dmitriy Minond. (2014) AlphaLISA-based high-throughput screening assay to measure levels of soluble amyloid precursor protein α. Analytical Biochemistry 459, pages 24-30.
Crossref
Crossref
David A. Bennett, Lei Yu & Philip L. De Jager. (2014) Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease. Biochemical Pharmacology 88:4, pages 617-630.
Crossref
Crossref
Igor Klyubin, Tomas Ondrejcak, Jennifer Hayes, William K. Cullen, Alexandra J. Mably, Dominic M. Walsh & Michael J. Rowan. (2014)
Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ
in vivo
. Philosophical Transactions of the Royal Society B: Biological Sciences 369:1633, pages 20130147.
Crossref
Crossref
Jan Korabecny, Filip Zemek, Ondrej Soukup, Katarina Spilovska, Kamil Musilek, Daniel Jun, Eugenie Nepovimova & Kamil Kuca. 2014. Drug Design and Discovery in Alzheimer's Disease. Drug Design and Discovery in Alzheimer's Disease
3
39
.
Carl L. Faingold. 2014. Neuronal Networks in Brain Function, CNS Disorders, and Therapeutics. Neuronal Networks in Brain Function, CNS Disorders, and Therapeutics
443
465
.
Christian Behl & Christine ZieglerChristian Behl & Christine Ziegler. 2014. Cell Aging: Molecular Mechanisms and Implications for Disease. Cell Aging: Molecular Mechanisms and Implications for Disease
99
108
.
S. Gauthier, A. Leuzy, E. Racine & P. Rosa-Neto. (2013) Diagnosis and management of Alzheimer's disease: Past, present and future ethical issues. Progress in Neurobiology 110, pages 102-113.
Crossref
Crossref
Michelle A. Lum, Gregor M. Balaburski, Maureen E. Murphy, Adrian R. Black & Jennifer D. Black. (2013) Heat Shock Proteins Regulate Activation-induced Proteasomal Degradation of the Mature Phosphorylated Form of Protein Kinase C. Journal of Biological Chemistry 288:38, pages 27112-27127.
Crossref
Crossref
John P. Dougherty & Jeff Oristaglio. (2013) Chronic treatment with the serotonin 2A/2C receptor antagonist SR 46349B enhances the retention and efficiency of rule-guided behavior in mice. Neurobiology of Learning and Memory 103, pages 50-63.
Crossref
Crossref
Elvira Valera & Eliezer Masliah. (2013) Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies. Pharmacology & Therapeutics 138:3, pages 311-322.
Crossref
Crossref
Hun-Bum Cho, Ji-Ha Park, Bu-Il Seo, Su-Yeon Cho, Kyu-Ryul Park, Seung-Hoon Choi, Chang-Kyun Han, Chang-Hyun Song, Soo-Jin Park & Sae-Kwang Ku. (2013) Single Oral Dose Toxicity Test of Persicae Semen Aqueous Extracts in Mice. The Korea Journal of Herbology 28:3, pages 17-24.
Crossref
Crossref
Fernando Peña-Ortega. (2013) Amyloid Beta-Protein and Neural Network Dysfunction. Journal of Neurodegenerative Diseases 2013, pages 1-8.
Crossref
Crossref
Zhanyang Yu, Jessica L. Poppe & Xiaoying Wang. (2013) Mitochondrial Mechanisms of Neuroglobin’s Neuroprotection. Oxidative Medicine and Cellular Longevity 2013, pages 1-11.
Crossref
Crossref
Marco Catto, Leonardo Pisani, Francesco Leonetti, Orazio Nicolotti, Paolo Pesce, Angela Stefanachi, Saverio Cellamare & Angelo Carotti. (2013) Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase. Bioorganic & Medicinal Chemistry 21:1, pages 146-152.
Crossref
Crossref
Sara Ansaloni, Brian P. Leung, Aditi Dubey & Aleister J. Saunders. (2012) Tyrosine kinase receptor B isoforms alter APP and BACE1 endogenous levels independently of BDNF. Advances in Alzheimer's Disease 01:03, pages 93-101.
Crossref
Crossref
. (2012) 8th Annual Conference of the European Nutraceutical Association (ENA). Annals of Nutrition and Metabolism 61:4, pages 322-336.
Crossref
Crossref